Company Profile

Employing proven, rapid, and inexpensive methods to capitalize on an extensive and ever-growing portfolio of patents covering a broad spectrum of potential products, Beech Tree Labs offers an attractive profile for investors and partners. Highlights include:

Novel Technology

• Typically comprised of naturally-occurring molecules;
• Physiologic dosage;
• Large portfolio of domestic and foreign patents and patent applications.

Innovative Platform

• Many unrelated diseases treated with different formulations by various investigators;
• Consistently positive results with placebo-level adverse effects.

The Company

• An established base of patented product candidates, several ready for formal clinical evaluation;
• Low burn rate and a proven cost and time effective product development strategy;
• Products with inherently low risk of side effects and high profit margin potential;
• No capital-intensive manufacturing process;
• Robust pipeline.

Management Team Successes

• 14 successful FDA-authorized clinical trials;
• 4 IRB-approved clinical trials;
• 2 USDA-authorized clinical trials.

Security

• All patents owned, or licensed to, the Company.